CCL21 and Carcinoma, Lewis Lung: Similarly, another DNA-based vaccine encoding SVN and chemokine CCL21 was shown to inhibit angiogenesis and induced potent CD8+ T cell and IFN-γ responses against Lewis lung carcinoma with significant prophylactic and therapeutic efficacy [27].